Total Credits: 1 including 1 AOA Category 1-A Credit(s)
Immunotherapy is a relatively new treatment for cancer patients. As more patients are treated, more auto-immune side effects are being noted. Many of these side effects are being managed by primary care physicians requiring the most up-to-date education regarding treatment. This lecture will outline the different types of immunotherapy, their uses and side-effects.
At the conclusion of this session, the participant should be able to:
Disclosure Statement: The speaker has no relevant financial relationship(s) with ineligible companies to disclose.
Accreditation Statement: The Pennsylvania Osteopathic Medical Association (POMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. POMA designates this live activity for a maximum of 1.0 Category 1-A AOA CME credits and will report CME and specialty credits to the AOA commensurate with the extent of the physician’s participation in this activity.
Grievance Statement: If you are not satisfied with the program, you may file a written grievance by emailing cme@poma.org. Your complaint will be forwarded to the Education Committee for review. The committee will determine if the participant should be reimbursed with no credits or deny the complaint and take the issue into consideration for future programs.
| POMA D8 22 - Moffa Handout (2.50 MB) | Available after Purchase | ||
Casey A. Moffa, DO, “Heme-Onc Immunotherapy: Overview for the PCP,” is an attending physician in hematology/oncology at West Penn Allegheny Oncology Network in Pittsburgh, Pennsylvania. Board certified in internal medicine, hematology and medical oncology, she is a graduate of Pennsylvania State University in State College and a 2006 graduate of Philadelphia College of Osteopathic Medicine. She completed an internship and internal medicine residency at The Western Pennsylvania Hospital in Pittsburgh, and a hematology/oncology fellowship at West Penn Allegheny Health System. Dr. Moffa is a member of POMA. She has no relevant financial relationship(s) with ineligible companies to disclose.